Emerging oseltamivir resistance in seasonal and pandemic influenza A/H1N1-Reference-Cited by-同舟云学术

Emerging oseltamivir resistance in seasonal and pandemic influenza A/H1N1

Published:2011-10 Issue:2 Volume:52 Page:70-78
ISSN:1386-6532
Container-title:Journal of Clinical Virology
language:en
Short-container-title:Journal of Clinical Virology

Author:

Renaud Christian,Kuypers Jane,Englund Janet A.

Publisher

Elsevier BV

Subject

Infectious Diseases,Virology

Reference114 articles.

1. Oseltamivir ring prophylaxis for containment of 2009 H1N1 influenza outbreaks;Lee;New Engl J Med,2010

2. Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008;Sheu;Antimicrob Agents Chemother,2008

3. WHO. Influenza A virus resistance to oseltamivir and other antiviral medicines. http://www.who.int/csr/disease/influenza/2008-9nhemisummaryreport/en/index.html; 2009.

4. Influenza hemagglutinin and neuraminidase membrane glycoproteins;Gamblin;J Biol Chem,2010

5. Permissive secondary mutations enable the evolution of influenza oseltamivir resistance;Bloom;Science,2010

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of RAN attenuates influenza a virus replication and nucleoprotein nuclear export;Emerging Microbes & Infections;2024-08-12

2. A small molecule compound targeting hemagglutinin inhibits influenza A virus and exhibits broad-spectrum antiviral activity;Acta Pharmacologica Sinica;2024-07-10

3. Efficacy and safety of intravenous peramivir versus oral oseltamivir in the treatment of influenza in children: A meta-analysis;Journal of Clinical Virology Plus;2024-06

4. Analysis of the epidemiological situation of influenza in Guangzhou under the prevention and control of COVID‐19 in June 2022;The Clinical Respiratory Journal;2024-05

5. Clinical outcomes of baloxavir versus oseltamivir in immunocompromised patients;Transplant Infectious Disease;2024-02-06